Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with V
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q3 2022 | VANILLIN | ORAL | TABLET, COATED PARTICLES | 1.50 mg | 12mg | Deletion | |
| Q2 2022 | VEGETABLE OIL GLYCERIDE, HYDROGENATED | ORAL | TABLET, EXTENDED RELEASE | 35 mg | MDE Replacement | ||
| Q3 2022 | VEGETABLE OIL GLYCERIDE, HYDROGENATED | ORAL | TABLET, EXTENDED RELEASE | 77mg | MDE Replacement | ||
| Q2 2022 | VEGETABLE OIL, HYDROGENATED | ORAL | CAPSULE | 261.00 mg | MDE Replacement | ||
| Q3 2022 | VEGETABLE OIL, HYDROGENATED | ORAL | CAPSULE | 311mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: July 1, 2022
Database Last Updated: July 18, 2022